US economic calendar today: Retail sales and PPI loom as Wall Street futures slip ahead of bank earnings

US economic calendar today: Retail sales and PPI loom as Wall Street futures slip ahead of bank earnings

NEW YORK, Jan 14, 2026, 06:47 ET — Premarket

Futures on U.S. stock indexes edged lower Wednesday ahead of major bank earnings and a U.S. data lineup that might shake up rate forecasts.

That’s significant since Tuesday’s consumer inflation report left the door open for Federal Reserve rate cuts later this year, though it didn’t nail down when. Attention now shifts to whether consumers continue to spend and if price pressures are showing up earlier in the supply chain.

Strong retail sales suggest demand remains steady. Meanwhile, a hotter producer price index might signal inflationary pressures brewing before they hit consumers.

By 5:10 a.m. ET, S&P 500 E-minis were down 12.25 points, or 0.17%. Dow E-minis dropped 83 points, also 0.17%, while Nasdaq 100 E-minis slipped 57.25 points, or 0.22%. Traders awaited earnings from Citigroup, Bank of America and Wells Fargo. Ahead of the open, Palo Alto Networks and Fortinet shares fell 3.3% and 2.5%, respectively. (Reuters)

Wall Street slipped on Tuesday, with financials dragging the indexes down. The Dow dropped 0.80% to 49,191.99, the S&P 500 slid 0.19% to 6,963.74, and the Nasdaq dipped 0.1% to 23,709.87. “These readings reinforce the notion that inflation is moderating,” said Gene Goldman, chief investment officer at Cetera Investment Management. (Reuters)

JPMorgan opened earnings season with a profit beat, yet its shares tumbled in volatile trading after executives voiced concerns over policy risks in consumer lending. CFO Jeremy Barnum warned that a 10% cap on credit-card rates “would be very bad for consumers” and would compel the bank to overhaul its business model. (Reuters)

Today’s economic docket includes the Census Bureau’s advance retail sales report for November, scheduled for 8:30 a.m. ET. The monthly retail trade report for October follows, with sales data at 8:30 a.m. and inventories at 10:00 a.m. Also at 8:30 a.m., the Labor Department will release November’s producer price index, closely monitored for signs of “pipeline” inflation. (Census)

The Fed will release its Beige Book at 2:00 p.m. ET, gathering anecdotal insights on economic conditions nationwide. Fed Governor Stephen Miran is slated to speak at 10:30 a.m., and New York Fed President John Williams will open a financial inclusion event at 2:10 p.m., per posted schedules. (Federal Reserve)

Following Tuesday’s CPI release, interest-rate futures pointed to a June cut as the favored next step, Reuters reported, with about a 40% chance of a reduction in April. Seema Shah, chief global strategist at Principal Asset Management, said, “A disinflationary trend is gradually taking shape.” (Reuters)

Early moves in cybersecurity were among the most dramatic. Chinese authorities have instructed domestic firms to ditch software from roughly a dozen U.S. and Israeli cybersecurity companies over national security worries, two sources told Reuters. Affected companies include Broadcom-owned VMware, Palo Alto Networks, Fortinet, and Israel’s Check Point Software. Reuters reported that neither Chinese regulators nor the companies responded to requests for comment. (Reuters)

The day could flip fast if retail sales report a steeper drop—or if producer prices pick up again, forcing investors to rethink easing expectations. Bank stocks are also weighed down by the ongoing buzz around credit-card rate caps. Plus, the crackdown on China’s software sector shows geopolitics still have bite in certain market segments.

Stock Market Today

  • Actinogen Medical and Top ASX Penny Stocks Show Potential Amid Market Headwinds
    February 4, 2026, 3:40 PM EST. The Australian stock market faces pressure from a Reserve Bank rate hike and international tech sell-offs, with ASX 200 futures hinting at a downturn. Yet, ASX penny stocks continue to offer investment opportunities due to their low price points and growth potential. Actinogen Medical (ASX:ACW), a pre-revenue biotechnology firm valued at A$153.2 million, is advancing its Alzheimer's treatment trial and recently secured A$17 million in funding. Despite current unprofitability, Actinogen's innovative approach could spur future revenue growth. Brisbane Broncos Limited (A$181.38 million market cap) operates debt-free in sports management, underlining stability. These stocks exemplify how smaller firms with strong fundamentals may thrive even amid broader market uncertainty.
Mortgage rates today: Rocket stock slips as 30-year fixed moves back above 6%
Previous Story

Mortgage rates today: Rocket stock slips as 30-year fixed moves back above 6%

Crude oil price climbs on Iran fears, lifting USO ETF and oil stocks before U.S. inventory data
Next Story

Crude oil price climbs on Iran fears, lifting USO ETF and oil stocks before U.S. inventory data

Go toTop